Business Wire

TX-AUREA-SOFTWARE-INC

11.1.2022 17:02:08 CET | Business Wire | Press release

Share
Deutsche Telekom Pilots New Virtual Office Powered by Sococo Software from Aurea

Aurea Software Inc. , the “Netflix of business software,” announced Deutsche Telekom is piloting its first-ever Virtual Office using Sococo software from Aurea . Used to better connect its distributed workforce and increase culture and collaboration across the company’s customer service teams, the pilot will run until March.

Deutsche Telekom customer service teams — comprised of 30,000 employees across Germany — are distributed throughout the country. Despite using a geographically distributed and hybrid work setting, team members need to be able to “work as one” to deliver optimal customer experiences.

Using Aurea’s Sococo solution, Deutsche Telekom is at the forefront of solving this problem of connection and culture in the geographically distributed and hybrid workplace by launching a Virtual Office that allows workers to enjoy the same level of connection and presence online that they once enjoyed in person.

“Hybrid work is here to stay. The pandemic started it, but workers embraced it, and there is no going back to a 100 percent in-person work world. And while research supports that working from home has many benefits, it also creates unique challenges,” said Scott Brighton, CEO of Aurea. “Workers can’t connect in the hallways the way they once did. They don’t meet new people on campus or when visiting other offices around the world. Common virtual meeting communication tools have made their work world smaller — encouraging them to stay in regular communication with people they already know, but not empowering them to discover new people or new ideas. This has led to a lack of experiencing a vibrant culture of diversity that was more prominent when workers came into a physical office.”

Brighton added, “With the creation of its Virtual Office, Deutsche Telekom is leading the industry by creating a hybrid-work environment that offers employees more ways to connect, collaborate, and build culture no matter where they are in the world.”

Deutsche Telekom’s Virtual Office looks and feels like an actual office — however, it’s online instead of in a physical building. There are gathering spaces, meeting and conference rooms, and even break areas, giving every employee the ability to see where colleagues are and what they are doing. This creates a rich sense of presence that is missing from basic communication tools that only show a generic status color next to a list of colleagues. Employees can meet and connect with new people using virtual meeting experiences specifically designed to create the casual connections present in in-office settings. For example, Deutsche Telekom’s Virtual Office has a Coffee Roulette room where employees are randomly connected to another co-worker they may not already know. They can spend a few minutes getting to know each other — sharing details about their roles, how they can help each other, and even what inspires them.

Aurea’s Sococo solution is centered around going beyond the basic communication aspects that traditional virtual meeting platforms provide to build true culture and connection.

“Like many large enterprises, Deutsche Telekom thrives, in part, due to the diverse backgrounds and skills of our workforce coming together to share knowledge and collaborate to solve customer issues more efficiently,” said Gereon Hammel, vice president of business development at Deutsche Telekom. “Many of the methods we’ve traditionally relied on to forge this collaboration are lost when functions are shrunk to closed and niche calls with immediate team members. By partnering with Aurea to launch this Virtual Office, we can enable important components of an in-person work environment within our hybrid work setting. This allows us to leverage our scale and diverse workforce, without requiring everyone to be in the same physical office space. The ease at which we can implement the Sococo solution across our team means our Virtual Office can be implemented in a matter of minutes.”

REGISTER TODAY : Hear more from Gereon Hammel and Scott Brighton on how to enable digital connection and build a Virtual Office during VentureBeat’s Future of Work Summit . Sign up today for the January 12 event.

About Aurea:

Aurea helps global businesses accelerate digital transformation through unlimited access to the world’s first business software library, which includes solutions that enable the Future of Commerce, work, and IT. Our customers enjoy access to every product in our portfolio, all of which are cloud-based, enterprise-scale, and easy-to-use with one simple subscription. Our unique operating model and acquisition strategy grows our software portfolio every year, creating unparalleled value and unlimited possibility. For more information, visit Aurea.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye